EUVIMEDSkopri EUVIMED
Crossref

Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway

Fengdan Wang, Yanqing Qi, Yakun Gao, Zhifang Wang, Xiaowei Shen, Hongyu Wu

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14326 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2023. Written by Fengdan Wang and 5 co-authors. Institution: Cardiovascular Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China. Major MEDLINE topics: Ferroptosis, HMGB1 Protein, Reperfusion Injury. Cited 13 times so far (Crossref); 36 references. Funded by: Natural Science Foundation of Ningbo.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ischemia/reperfusion (I/R) of skeletal muscle in the lower limbs is an important factor affecting the outcome of lower limbs ischemia patients, with no effective preventive or therapeutic approaches available. The study was to investigate the effect of syringic acid (SA) on I/R skeletal muscle in the lower limbs injury. Mice femoral artery I/R models and C2C12 cell hypoxia/reoxygenation (H/R) models was establish, tissue damage, inflammatory status, and high mobility group box 1 (HMGB1) pathway were evaluated using histological analysis, enzyme‐linked immunosorbent assay, and western blotting. Further, the study detected the effect of SA on cell apoptosis, lipid peroxidation, Fe 2+ level, and ferroptosis‐related proteins expression. Finally, the effect of HMGB1 expression on SA in H/R stimulation was studied. SA alleviated pathological damage and reduced levels of IL‐1β, IL‐6, and TNF‐α in muscle tissues from femoral artery I/R mouse models. SA upregulated Bcl‐2 and SOD as well as downregulated Bax, MDA, TBARS content, and Fe 2+ level in H/R‐induced cells. SA inhibited HMGB1 expression and promoted Nrf2, HO‐1, GPX4, and SLC7A11 expressions in the injured tissues and cells. Such effects of SA on H/R‐induced cells were rescued by HMGB1 overexpression. SA suppressed ferroptosis of skeletal muscle cells to alleviate lower limb I/R injury in mice by blocking the HMGB1 pathway, providing new insights for the treatment of lower limb ischemia–reperfusion injury.

Subjects

MeSH terms (MEDLINE)

FerroptosisHMGB1 ProteinReperfusion InjuryHumansMiceAnimalsSignal TransductionIschemiaLower ExtremityMuscle, SkeletalGallic Acid

Author keywords

ferroptosishigh mobility group box 1limb ischemia/reperfusion injurysyringic acid

Substances

HMGB1 Proteinsyringic acidGallic Acid

Authors and institutions

  • Cardiovascular Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China.

Funding

  • Natural Science Foundation of Ningbo

Cite

APA

Wang, F., Qi, Y., Gao, Y., Wang, Z., Shen, X., & Wu, H. (2023). Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14326

Vancouver

Wang F, Qi Y, Gao Y, Wang Z, Shen X, Wu H. Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14326

BibTeX
@article{Wang2023,
  author = {Wang, Fengdan and Qi, Yanqing and Gao, Yakun and Wang, Zhifang and Shen, Xiaowei and Wu, Hongyu},
  title = {Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14326}
}
Start for free →